The global Bare-metal Stents Market was valued at USD 3.1 billion in 2022 and is projected to surpass USD 4.8 billion by the end of 2031. The market is expected to grow at a CAGR of 5.2% from 2023 to 2031, driven by the increasing prevalence of cardiovascular diseases, rising demand for minimally invasive procedures, and growing adoption of advanced coronary intervention technologies. Expanding healthcare infrastructure and increasing awareness regarding early treatment of cardiac disorders are also supporting the steady growth of the market worldwide.

Rise in advancements in technology and increase in awareness among healthcare professionals and patients about the advantages of stents in treating coronary artery disease are the key growth drivers of the bare-metal stents market. Focus on development of new generation of bare-metal stents with better biocompatibility and improved safety profiles has improved outcomes and reduced risk of thrombosis. This has further augmented the global bare-metal stents market development.

Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=72336

Rise in demand for minimally invasive procedures and better patient outcomes is expected to bolster the bare-metal stents industry. Development of innovative products that offer superior performance and safety offers lucrative opportunities to market players. Key players are investing significantly in research & development to strengthen presence in the market.

Key Findings of the Market Report

• Peripheral Dominance: BMS are projected to hold a staggering 80.5% share of the peripheral stent implant market by 2035, valued for their mechanical integrity in high-stress vascular environments.
• Material Trends: Cobalt-chromium has largely replaced stainless steel as the material of choice, accounting for over 65% of new BMS shipments due to improved flexibility and radiopacity.
• High Bleeding Risk (HBR) Patients: BMS remain the preferred option for the roughly 15–20% of PCI patients who cannot tolerate long-term blood thinners.
• Hospital Preference: The hospital segment remains the largest end-user, accounting for approximately 73.6% of revenue, as these facilities handle the majority of complex cardiovascular emergencies.

Global Market: Growth Drivers

• Rising Prevalence of Peripheral Artery Disease (PAD): Global PAD incidence increased significantly over the last decade, creating a massive secondary market for robust bare-metal scaffolding.
• Cost-Effectiveness in Emerging Markets: In regions with high out-of-pocket healthcare costs, BMS serve as a vital, lower-cost alternative to premium drug-eluting technologies.
• Aging Global Population: The "geriatric bulge" is leading to more frequent cardiovascular interventions, sustaining a baseline demand for traditional stenting solutions.
• Advancements in Delivery Systems: New "low-profile" delivery catheters have made BMS easier to deploy in tortuous or calcified anatomy, expanding their utility in difficult cases.

Global Market: Key Players

The BMS landscape is led by major diversified medical technology corporations with established global distribution networks.

• Abbott Laboratories (Leading global market share at ~23.5%)
• Medtronic plc
• Boston Scientific Corporation
• Terumo Corporation
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• Cook Medical
• Cardinal Health (Cordis)
• C. R. Bard, Inc. (Becton Dickinson)

Global Market: Segmentation

By Application

• Coronary Bare-metal Stents: Used for heart-related artery blockages; maintains a steady niche in HBR patients.
• Peripheral Bare-metal Stents: Leading segment for iliac, femoral, and renal artery interventions.

By Type

• Balloon-Expandable: Preferred for high-precision placement in coronary and renal arteries.
• Self-Expanding: Typically used in peripheral vessels (like the carotid or popliteal) that require flexibility and resistance to external compression.

By Material

• Cobalt-Chromium: The modern standard for thin-strut designs.
• Stainless Steel: Still utilized for larger-diameter peripheral stents where bulk strength is paramount.
• Platinum-Chromium: Emerging premium material offering the highest levels of visibility.

By End-User

• Hospitals: Primary site for acute myocardial infarction and complex vascular surgeries.
• Ambulatory Surgical Centers (ASCs): The fastest-growing segment (9.1% CAGR) as more routine stenting procedures migrate to outpatient settings.

Buy this Premium Research Report:  https://www.transparencymarketresearch.com/checkout.php?rep_id=72336&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com 
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com